Genzyme Corporation Prices Private Senior Notes Offerings

Published: Jun 15, 2010

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (NASDAQ: GENZ) announced today that it priced private offerings for $1 billion in senior notes. The net proceeds from these offerings will be used to repurchase the first tranche of the previously announced $2 billion stock buyback plan. The stock repurchase is part of the company’s plan to increase shareholder value.

Back to news